EGFR-HER2 inhibitor, Lifirafenib, Purity ≥98%

Synonym: 1446090-77-2; BGB-283; BGB283; BGB 283; 5-[[(1R,1aS,6bR)-1-[6-(Trifluoromethyl)-1H-benzimidazol-2-yl]-1a,6b-dihydro-1H-cyclopropa[b][1]benzofuran-5-yl]oxy]-3,4-dihydro-1H-1,8-naphthyridin-2-one

CAS Number: 1446090-77-2
Compound CID: 89670174

Product Size

5 mg; 10 mg; 50 mg; 100 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

Lifirafenib is an effective JAK-Stat inhibitor, that has the ability to prevent the pathway of protein tyrosine kinases by inhibiting EGFR-HER2.

Molecular Weight

478.42

Molecular Formula

C₂₅H₁₇F₃N₄O₃

Form

Lyophilized powder

Purity

≥98%

Titer

Free from inappropriate visible particulates, foreign matter, discoloration, or other defects

Applications

Lifirafenib is a protein tyrosine kinase inhibitor that can be studied extensively for its potential therapeutic applications in the treatment of certain types of cancer, such as melanoma and other solid tumors.